In spite of this underperformance, the clinical-stage TechBio firm continues to attract interest for its innovative approach to drug discovery driven by AI and ...

D-Wave Quantum QBTS is accelerating its momentum across both real-world quantum AI applications and deep tech hardware ...

AI-led drug for chronic lung disease set to enter phase 3 clinical trials, though experts remain divided on AI's impact in ...

In this symposium, an expert panel will discuss how the latest organoid models help researchers discover and develop new ...

To ensure the continued operation and advancement of the innovative models and mechanisms cultivated in DAIIA, Elix -- which already operates its own AI drug discovery platform -- and LINC -- a ...